Target intelligence / Profile preview

Phagosomal membrane of antigen-presenting cells

Molecular classification
Cellular compartment, Organelle membrane
01

Overview

The phagosomal membrane of antigen-presenting cells (APCs), such as macrophages and dendritic cells, is a dynamic lipid bilayer that forms around ingested particles during phagocytosis [Savina & Amigorena, 2007, Immunol Rev]. It serves as a critical platform for the innate and adaptive immune responses, facilitating the degradation of pathogens and the subsequent processing of antigens for presentation on MHC molecules [Guermonprez et al., 2002, Nature]. The membrane contains various proteins, including proton pumps (V-ATPases) for acidification, NADPH oxidase for reactive oxygen species production, and Toll-like receptors (TLRs) for pathogen recognition [Flannagan et al., 2009, Nat Rev Microbiol]. While not a single molecular target, the phagosomal membrane and its associated processes are focal points for therapeutic intervention in infectious diseases, where pathogens like Mycobacterium tuberculosis evade destruction by manipulating membrane fusion [Russell, 2001, Nat Rev Mol Cell Biol]. Additionally, modulating phagosomal functions, such as pH or maturation rate, is a strategy in cancer immunotherapy to enhance the cross-presentation of tumor antigens to CD8+ T cells [Joffre et al., 2012, Nat Rev Immunol]. Drugs like chloroquine interact with this compartment by neutralizing its acidic environment, thereby affecting antigen processing and viral entry [Savarino et al., 2003, Lancet Infect Dis].

Other names
Phagosome membranePhagocytic vacuole membraneAPC phagosomal membrane
02

Mechanism of action

Modulation of phagosomal pH and inhibition of phagosome-lysosome fusion

03

Biological functions

PhagocytosisAntigen processingAntigen presentationPhagosome maturationPathogen degradation
04

Disease associations

InfectionCancerAutoimmune disease
05

Safety considerations

Systemic lysosomal dysfunctionImpaired immune response to pathogensPotential for drug-induced phospholipidosis
06

Interacting drugs

Chloroquine

3 more in the full profile.

07

Biomarkers

LAMP-1Rab5Rab7V-ATPase

Beyond the preview

Go deeper on Phagosomal membrane of antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phagosomal membrane of antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call